Overview Anti-infectives: Recent advances in the treatment of septic shock
- 1 August 1994
- journal article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Patents
- Vol. 4 (8) , 917-930
- https://doi.org/10.1517/13543776.4.8.917
Abstract
(1994). Overview Anti-infectives: Recent advances in the treatment of septic shock. Expert Opinion on Therapeutic Patents: Vol. 4, No. 8, pp. 917-930. doi: 10.1517/13543776.4.8.917Keywords
This publication has 47 references indexed in Scilit:
- Nitric oxide as a target for therapy in septic shockCritical Care Medicine, 1993
- Design of potent, cyclic peptide bradykinin receptor antagonists from conformationally constrained linear peptidesJournal of Medicinal Chemistry, 1993
- Mediators of septic shockCritical Care Medicine, 1993
- Interleukin-10Annual Review of Immunology, 1993
- A soluble receptor for interleukin-1β encoded by vaccinia virus: A novel mechanism of virus modulation of the host response to infectionCell, 1992
- Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding proteinCell, 1992
- A rationale for the prophylactic use of monophosphoryl lipid A in sepsis and septic shockBiochemical and Biophysical Research Communications, 1992
- CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding ProteinScience, 1990
- Human Monoclonal Antibody with Protective Activity for Escherichia coli K1 and Neisseria meningitidis Group B InfectionsThe Journal of Infectious Diseases, 1987
- Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coliNew England Journal of Medicine, 1982